2015PubMedRequires access

Chlorthalidone vs. Hydrochlorothiazide for Treatment of Hypertension.

Karyn Springer

Open publisher page 5 citations

Abstract

Chlorthalidone produces slightly greater reductions in blood pressure compared with hydrochlorothiazide (HCTZ), but it is associated with greater declines in serum potassium levels. Chlorthalidone lowers the risk of cardiovascular events about 18% more than HCTZ at the same achieved blood pressure.

About this research paper

What this paper is about

Chlorthalidone produces slightly greater reductions in blood pressure compared with hydrochlorothiazide (HCTZ), but it is associated with greater declines in serum potassium levels. Chlorthalidone lowers the risk of cardiovascular events about 18% more than HCTZ at the same achieved blood pressure.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Chlorthalidone produces slightly greater reductions in blood pressure compared with hydrochlorothiazide (HCTZ), but it is associated with greater declines in serum potassium levels. Chlorthalidone lowers the risk of cardiovascular events about 18% more than HCTZ at the same achieved blood pressure.

Key concepts: Chlorthalidone, Hydrochlorothiazide, Medicine, Blood pressure, Thiazide, Internal medicine, Diuretic, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Chlorthalidone vs. Hydrochlorothiazide for Treatment of Hypertension. — Research Paper | ScholarLens